From FoxNews.com…
The Food and Drug Administration (FDA) loosened restrictions on telemedicine abortionsin a letter Thursday that officially reversed an in-person dispensing requirement maintained by the Trump administration.
“After conducting a review of the single, shared system Risk Evaluation and Mitigation Strategy (REMS) for mifepristone, known as the Mifepristone REMS Program, FDA determined that the data support modification of the REMS to reduce burden on patient access and the health care delivery system and to ensure the benefits of the product outweigh the risks,” the FDA said on its “Questions and Answers on Mifepristex” page.
It also included a requirement that pharmacies dispensing the drug be certified.
